In ovo DNA immunisation followed by a recombinant fowlpox boost is fully protective to challenge with virulent IBDV

Vaccine

Volumn 24, Issue 23, 2006, Pages 4951-4961

  Haygreen, E A ^a   Kaiser, P ^a   Burgess, S C ^a   Davison, T F ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

DNA vaccine; IBDV; In ovo vaccination

Indexed keywords

BETA GALACTOSIDASE; DNA VACCINE; INFECTIOUS BURSAL DISEASE 1 PROTEIN; PLASMID DNA; PRIMER DNA; PROTEIN VP2; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; AVIAN STOMACH; CELL PROTECTION; CELL STIMULATION; CELLULAR IMMUNITY; CHICK; DNA VECTOR; DRUG USE; EMBRYO; FOWLPOX VIRUS; GENE EXPRESSION; GENE LOCATION; GENETIC CODE; IMMUNOGENICITY; INFECTIOUS BURSAL DISEASE VIRUS; INJECTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; RNA VIRUS INFECTION; THYMUS; VIRAL GENE DELIVERY SYSTEM; VIRUS VIRULENCE;

AMNIOTIC FLUID; ANIMALS; BIRNAVIRIDAE INFECTIONS; CHICK EMBRYO; CHICKENS; DEOXYRIBONUCLEASES; DNA, RECOMBINANT; FOWLPOX VIRUS; IMMUNIZATION, SECONDARY; INFECTIOUS BURSAL DISEASE VIRUS; POULTRY DISEASES; RNA, VIRAL; VACCINES, DNA; VIRAL VACCINES; VIRULENCE;

EID: 33646863430     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.03.060     Document Type: Article

References (69)

1. Cosgrove A.S. An apparently new disease of chickens-avian nephrosis. Avian Dis 6 (1962) 385-389
2. Pringle C.R. The universal system of virus taxonomy of the International Committee on Virus Taxonomy (ICTV), including new proposals ratified since publication of the Sixth ICTV Report in 1995. Arch Virol 143 (1998) 203-210
3. Kibenge F.S.B., Dhillon A.S., and Russell R.G. Biochemistry and immunology of infectious bursal disease virus. J Gen Virol 69 (1988) 1757-1775
4. Dobos P., Hill B.J., Hallett R., Kells D.T.C., Becht H., and Teninges D. Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J Virol 32 (1979) 593-605
5. Hirai K., and Calnek B.W. In vitro replication of infectious bursal disease virus in established lymphoid cell lines and chicken B lymphocytes. Infect Immunity 25 (1979) 964-970
6. Hirai K., Funakoshi T., Nakai T., and Shimakura S. Sequential changes in the number of surface immunoglobulin bearing B lymphocytes in infectious bursal disease virus infected chickens. Avian Dis 25 (1981) 484-496
7. Bottcher B., Kiselev N.A., Stel'Mashchuk V.Y., Perevozchikova N.A., Borisov A.V., and Crowther R.A. Three-dimensional structure of infectious bursal disease virus determined by electron cryomicroscopy. J Virol 71 (1997) 325-330
8. Caston J.R., Martinez-Torrecuadrada J.L., Maraver A., Lombardo E., Rodriguez J.F., Casal J.I., et al. C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly. J Virol 75 (2001) 10815-10828
9. Fahey K.J., Erny K., and Crooks J. A conformational immunogen on VP2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J Gen Virol 70 (1989) 1473-1481
10. Benton W.J., Cover J.K., and Rosenberger J.K. Studies on the transmission of the infectious bursal agent (IBA) of chickens. Avian Dis 11 (1967) 430-438
11. Wyeth P.J., and Cullen G.A. The use of an inactivated infectious bursal disease oil emulsion vaccine in commercial broiler parent chickens. Vet Rec 104 (1979) 188-193
12. Chettle N., Stuart J.C., and Wyeth P.J. Outbreak of virulent infectious bursal disease in East Anglia. Vet Rec 125 (1989) 271-272
13. Chettle N.J., and Wyeth P.J. Failure of maternally derived infectious bursal disease antibodies to serotype-1 and serotype-2 to protect against heterologous virus. Br Vet J 145 (1989) 165-169
14. van den Berg T.P., and Meulemans G. Acute infectious bursal disease in poultry-protection afforded by maternally derived antibodies and interference with live vaccination. Avian Pathol 20 (1991) 409-421
15. van den Berg T.P., Gonze M., and Meulemans G. Acute infectious bursal disease in poultry-isolation and characterization of a highly virulent strain. Avian Pathol 20 (1991) 133-143
16. Naqi S.A., Miller D.L., and Grumbles L.C. An evaluation of three commercially available infectious bursal disease vaccines. Avian Dis. 24 (1980) 233-240
17. Ahmad J., and Sharma J.M. Protection against hemorrhagic enteritis and Newcastle-disease in turkeys by embryo vaccination with monovalent and bivalent vaccines. Avian Dis 37 (1993) 485-491
18. Sharma J.M., and Burmester B.R. Resistance to Mareks disease at hatching in chickens vaccinated as embryos with the turkey Herpesvirus. Avian Dis 26 (1982) 134-149
19. Sharma J.M., Lee L.F., and Wakenell P.S. Comparative viral, immunologic, and pathologic responses of chickens inoculated with herpesvirus of turkeys as embryos or at hatch. Am J Vet Res 45 (1984) 1619-1623
20. Gildersleeve R., Hoyle C.M., Miles A.M., Murray D.L., Ricks C.A., Secrest M.N., et al. Development performance of an egg injection machine for administration of Marek's disease. J Appl Poultry Res 2 (1993) 337-346
21. Islam A.F.M.F., Walkden-Brown S.W., Wong C.W., Groves P.J., Burgess S.K., Arzey K.E., et al. Influence of vaccine deposition site on post-vaccinal viraemia and vaccine efficacy in broiler chickens following in ovo vaccination against Marek's disease. Avian Pathol 30 (2001) 525-533
22. Jochemsen P., and Jeurissen S.H.M. The localisation and uptake of in ovo injected soluble and particulate substances in the chicken. Poultry Sci 81 (2002) 1811-1817
23. Tang D.C., Devit M., and Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 356 (1992) 152-154
24. Hulse D.J., and Romero C.H. Partial protection against infectious bursal disease virus through DNA-mediated vaccination with the VP2 capsid protein and chicken IL-2 genes. Vaccine 22 (2004) 1249-1259
25. Chang H.C., Lin T.L., and Wu C.C. DNA-mediated vaccination against infectious bursal disease in chickens. Vaccine 20 (2001) 328-335
26. Chang H.C., Lin T.L., and Wu C.C. DNA vaccination with plasmids containing various fragments of large segment genome of infectious bursal disease virus. Vaccine 21 (2003) 507-513
27. Fodor I., Horvath E., Fodor N., Nagy E., Rencendorsh A., Vakharia V.N., et al. Induction of protective immunity in chickens immunised with plasmid DNA encoding infectious bursal disease virus antigens. Acta Vet Hungarica 47 (1999) 481-492
28. Heckert R.A., Elankumaran S., Oshop G.L., and Vakharia V.N. A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization. Vet Immunol Immunopathol 89 (2002) 67-81
29. Li J.R., Huang Y.W., Liang X.Y., Lu M.J., Li L., Yu L., et al. Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy. Virus Res 98 (2003) 63-74
30. Li J.R., Liang X.Y., Huang Y.W., Meng S.S., Xie R.H., Deng R.T., et al. Enhancement of the immunogenicity of DNA vaccine against infectious bursal disease virus by co-delivery with plasmid encoding chicken interleukin 2. Virology 329 (2004) 89-100
31. Wang X.Q., Jiang P., Deen S., Wu J.Q., Liu X.W., and Xua J.R. Efficacy of DNA vaccines against infectious bursal disease virus in chickens enhanced by coadministration with CpG oligodeoxynucleotide. Avian Dis 47 (2003) 1305-1312
32. Oshop G.L., Elankumaran S., Vakharia V.N., and Heckert R.A. In ovo delivery of DNA to the avian embryo. Vaccine 21 (2003) 1275-1281
33. Kapczynski D.R., Hilt D.A., Shapiro D., Sellers H.S., and Jackwood D.J. Protection of chickens from infectious bronchitis by in ovo and intramuscular vaccination with a DNA vaccine expressing the S1 glycoprotein. Avian Dis 47 (2003) 272-285
34. Schneider J., Gilbert S.C., Blanchard T.J., Hanke T., Robson K.J., Hannan C.M., et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 4 (1998) 397-402
35. Robinson H.L., Montefiori D.C., Johnson R.P., Manson K.H., Kalish M.L., Lifson J.D., et al. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med 5 (1999) 526-534
36. Bayliss C.D., Peters R.W., Cook J.K.A., Reece R.L., Howes K., Binns M.M., et al. A recombinant fowlpox virus that expresses the Vp2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch Virol 120 (1991) 193-205
37. Butter C., Sturman T.D.M., Baaten B.J.G., and Davison T.F. Protection from infectious bursal disease virus (IBDV)-induced immunosuppression by immunization with a fowlpox recombinant containing IBDV-VP2. Avian Pathol 32 (2003) 597-604
38. Shaw I., and Davison T.F. Protection from IBDV-induced bursal damage by a recombinant fowlpox vaccine, fpIBD1, is dependent on the titre of challenge virus and chicken genotype. Vaccine 18 (2000) 3230-3241
39. Bygrave A.C., and Faragher J.T. Mortality associated with Gumboro disease. Vet Rec (1970) 758-759
40. van Loon A.A.W.M., Lutticken D., and Snyder D.B. Rapid quantification of infectious bursal disease (IBD) challenge, field or vaccine virus strains. International symposium on infectious bursal disease and chicken infectious anaemia (1994), Rauischholzhausen, Germany 179-187
41. Bayliss C.D., Spies U., Shaw K., Peters R.W., Papageorgiou A., Muller H., et al. A comparison of the sequences of segment-A of 4 infectious bursal disease virus strains and identification of a variable region in Vp2. J Gen Virol 71 (1990) 1303-1312
42. Lejal N., DaCosta B., Huet J., and Delmas B. Role of Ser-652 and Lys-692 in the protease activity of infectious bursal disease virus VP4 and identification of its substrate cleavage sites. J Gen Virol 81 (2000) 983-992
43. Snyder D.B., Lana D.P., Cho B.R., and Marquardt W.W. Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies. Avian Dis 32 (1988) 527-534
44. Sharma J.M., and Burmester B.R. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis 26 (1982) 134-149
45. Moody A., Sellers S., and Bumstead N. Measuring infectious bursal disease virus RNA in blood by multiplex real-time quantitative RT-PCR. J Virol Meth 85 (2000) 55-64
46. Williams A. The pathogenesis of very virulent infectious bursal disease virus and its modulation by DNA vaccination, PhD Thesis, Royal Veterinary College, University of London, 2002.
47. Hulse D.J., and Romero C.H. Fate of plasmid DNA encoding infectious bursal disease virus VP2 capsid protein after injection into the pectoralis muscle of the chicken. Poultry Sci 81 (2002) 213-216
48. Hudson L., and Roitt I.M. Immunofluorescent detection of surface antigens specific to T and B lymphocytes in chicken. Eur J Immunol 3 (1973) 63-67
49. Woods R., and Linna J. Transport of cells from bursa of Fabricius to spleen and thymus. Acta Pathol Microbiol Scand 64 (1965) 470-478
50. Albini B., and Wick G. Delineation of B lymphoid and T lymphoid cells in chicken. J Immunol 112 (1974) 444-450
51. Toivanen P., Toivanen A., Good R.A., and Linna T.J. Ontogeny of bursal function in chicken. 2. Postembryonic stem cell for humoral immunity. J Immunol 109 (1972) 1071-1079
52. Tamminen P., Toivanen A., and Toivanen P. Density gradient separation of chicken thymus cells. Eur J Immunol 3 (1973) 521-523
53. Jankovic B.D., Isakovic K., and Petrovic S. Direct stimulation of lymphoid tissue of the chicken. II. Changes in lymphoid organs following intrathymic and intravenous injection of antigen. Eur J Immunol 2 (1972) 25-31
54. Frazier J.A. Ultrastructure of the chick thymus. Z. Zellforsch 136 (1973) 191-205
55. Rautenschlein S., Yeh H.Y., Njenga M.K., and Sharma J.M. Role of intrabursal T cells in infectious bursal disease virus (IBDV) infection: T cells promote viral clearance but delay follicular recovery. Arch Virol 147 (2002) 285-304
56. Rautenschlein S., Yeh H.Y., and Sharma J.M. The role of T cells in protection by an inactivated infectious bursal disease virus vaccine. Vet Immunol Immunopathol 89 (2002) 159-167
57. Yeh H.Y., Rautenschlein S., and Sharma J.M. Protective immunity against infectious bursal disease virus in chickens in the absence of virus-specific antibodies. Vet Immunol Immunopathol 89 (2002) 149-158
58. Tanimura N., and Sharma J.M. Appearance of T cells in the bursa of Fabricius and cecal tonsils during the acute phase of Infectious bursal disease virus infection in chickens. Avian Dis 41 (1997) 638-645
59. Kim I.J., You S.K., Kim H., Yeh H.Y., and Sharma J.M. Characteristics of bursal T lymphocytes induced by infectious bursal disease virus. J Virol 74 (2000) 8884-8892
60. Sharma J.M., Kim I.J., Rautenschlein S., and Yeh H.Y. Infectious bursal disease virus of chickens: pathogenesis and immunosuppression. Devel Comp Immunol 24 (2000) 223-235
61. Vervelde L., and Davison T.F. Comparison of the in situ changes in lymphoid cells during infection with infectious bursal disease virus in chickens of different ages. Avian Pathol 26 (1997) 803-821
62. Estcourt M.J., Ramsay A.J., Brooks A., Thomson S.A., Medveckzy C.J., and Ramshaw I.A. Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population. Int Immunol 14 (2002) 31-37
63. Gilbert S.C., Schneider J., Hannan C.M., Hu J.T., Plebanski M., Sinden R., et al. Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. Vaccine 20 (2002) 1039-1045
64. McShane H., Brookes R., Gilbert S.C., and Hill A.V.S. Enhanced immunogenicity of CD4(+) T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect Immunity 69 (2001) 681-686
65. + T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost. Vaccine 21 (2003) 4555-4564
66. Kent S.J., Zhao A., Best S.J., Chandler J.D., Boyle D.B., and Ramshaw I.A. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J Virol 72 (1998) 10180-10188
67. Chastain M., Simon A.J., Soper K.A., Holder D.J., Montgomery D.L., Sagar S.L., et al. Antigen levels and antibody titers after DNA vaccination. J Pharmaceut Sci 90 (2001) 474-484
68. Mora J.R., Bono M.R., Manjunath N., Weninger W., Cavanagh L.L., Rosemblatt M., et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424 (2003) 88-93
69. Russell P.H., and Mackie A. Eye-drop DNA can induce IgA in the tears and bile of chickens. Vet Immunol Immunopathol 80 (2001) 327-332